Mark Copley Focuses on Bioequivalence Testing for Generics at 6th IPA Symposium
Mark Copley, Sales Director for Copley Scientific, will deliver a presentation at the Indian Pharmaceutical Association’s (IPA) 6th symposium on nasal and pulmonary drug delivery (24–25 October 2013, Mumbai) to discuss bioequivalence testing for inhaled generics. This year, the event will focus on global regulatory trends in inhaled product testing and development. To find out more or to register please visit www.ipapharma.org
The Indian pharmaceutical industry is a global leader in the development of generic inhaled products, primarily for the treatment of chronic obstructive pulmonary diseases (COPD) and asthma. Demonstrating bioequivalence through in vitro testing minimises the need for clinical trials, accelerating time to market and reducing development costs. In a presentation, entitled “Methodologies for in vitro bioequivalence testing of generic inhaled products in emerging markets”, Mr Copley will review the regulatory framework in this area and outline efficient testing strategies that can be used to fulfil the associated requirements.
Copley Scientific is s world-leading manufacturer and supplier of inhaler test equipment with a track record of innovating new products to meet evolving requirements for both novel and generic inhaled product testing. Solutions of particular value for generic testing include a range of equipment for delivered dose uniformity and aerodynamic particle size measurement, cost-efficient breathing simulators for nebuliser testing, and unique instruments such as the Plume Temperature Tester Model PTT 1000 for measurement of the Cold Freon effect. In combination with Copley Scientific’s expert support these products help generics manufacturers to fully meet regulatory requirements and bring new products to market quickly and efficiently.
Related News
-
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News Biden backs Cold-War measures to shore-up medical supply chains
In a recent strategy to combat rising inflation and the cost of living crisis, President Joe Biden has invoked a Cold War-era act to increase investment in a selection of medicines and supplies. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Novartis agrees for copies to be made of cancer drug to reach poorer countries
Novartis signs agreement with MPP to have generics of it's leukemia drug made so that it can be more easily distributed to the world's poorer countries. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute. -
News New WHO health emergency guidelines expect full transparency from Big Pharma
The WHO are proposing a new set of pandemic guidelines to set out how future global health crises should be handled.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance